FRATES JAMES M 内部人交易：近期 SEC Form 4 交易
过去 18 个月，FRATES JAMES M（CIK 1235598）在 2 家公司共报告 9 笔 SEC Form 4 内部人交易（最近一笔 2026-09-14）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-14 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Financial Officer | 卖出 | 9,768 | $315,195 |
| 2026-09-14 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Financial Officer | 卖出 | 1,042 | $34,626 |
| 2026-08-20 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Financial Officer | 买入 | 22,807 | $0 |
| 2026-03-09 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Financial Officer | 买入 | 95,990 | $0 |
| 2026-03-04 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Financial Officer | 卖出 | 7,909 | $114,839 |
| 2026-02-04 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Financial Officer | 卖出 | 3,557 | $52,110 |
| 2026-01-08 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Financial Officer | 卖出 | 3,326 | $36,952 |
| 2025-10-02 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Financial Officer | 卖出 | 10,558 | $154,675 |
| 2025-07-31 | Sage Therapeutics, Inc. (SAGE) | 董事 | 卖出 | 2,845 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-14